Optellum
PrivateLast Round
Series B
Jan 8, 2024
Total Funding Raised
$18.58M
Company Overview
Optellum is a medical technology company that has developed an AI-powered platform for the early diagnosis and treatment of lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optellum Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Optellum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 8, 2024 | ||||
| Series A | Sep 27, 2022 | ||||
| Seed | Jul 15, 2019 | ||||
| Grant | Dec 1, 2016 | ||||
| Grant | Oct 1, 2016 |
Key People
Founding team and executive leadership
Optellum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
| IQ Capital | Series A, Seed |
| Intuitive Ventures | Series B, Series A |
| Healthliant Ventures | Series B |
| Woori Venture Partners Co., Ltd. | Series B |
| Innovate UK | Grant |
| St. John's College, Oxford | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2025
Partnering with Bristol Myers Squibb on AI for early diagnosis and precision care.
- Mar 4, 2025
Partnered with Volpara Health to expand cancer risk detection.
Optellum Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Optellum's valuation, stock price, and market status.